Which has higher earnings and valuation, SDGR or DOCS?

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $259.04M 8.33 -$103.26M -$0.74 N/A Doximity $644.86M 7.33 $196.05M $0.85 31.21

Is SDGR or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Doximity 25.48% 18.06% 15.40%

Does the media refer more to SDGR or DOCS?

In the previous week, Doximity had 20 more articles in the media than Schrodinger. MarketBeat recorded 35 mentions for Doximity and 15 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.71 beat Doximity's score of 0.01 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 7 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 2 Very Positive mention(s) 2 Positive mention(s) 26 Neutral mention(s) 2 Negative mention(s) 3 Very Negative mention(s) Neutral

Which has better valuation and earnings, SDGR or WAY?

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $259.04M 8.33 -$103.26M -$0.74 N/A Waystar $1.21B 3.94 $112.09M $0.70 35.37

Is SDGR or WAY more profitable?

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Waystar 11.18% 7.03% 4.75%

Does the media favor SDGR or WAY?

In the previous week, Schrodinger had 12 more articles in the media than Waystar. MarketBeat recorded 15 mentions for Schrodinger and 3 mentions for Waystar. Schrodinger's average media sentiment score of 0.71 beat Waystar's score of 0.50 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 7 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waystar 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, HTFL or SDGR?

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 23.41 -$116.79M -$1.83 N/A Schrodinger $259.04M 8.33 -$103.26M -$0.74 N/A

Is HTFL or SDGR more profitable?

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% Schrodinger -20.98% -16.37% -8.19%

Does the media refer more to HTFL or SDGR?

In the previous week, Heartflow had 2 more articles in the media than Schrodinger. MarketBeat recorded 17 mentions for Heartflow and 15 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.71 beat Heartflow's score of 0.35 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 6 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Schrodinger 7 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, GDRX or SDGR?

GoodRx has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.43 $30.44M $0.04 83.00 Schrodinger $259.04M 8.33 -$103.26M -$0.74 N/A

Is GDRX or SDGR more profitable?

GoodRx has a net margin of 2.07% compared to Schrodinger's net margin of -20.98%. GoodRx's return on equity of 7.22% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Schrodinger -20.98% -16.37% -8.19%

Which has preferable earnings and valuation, CERT or SDGR?

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $421.75M 3.12 -$1.60M -$0.45 N/A Schrodinger $259.04M 8.33 -$103.26M -$0.74 N/A

Is CERT or SDGR more profitable?

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Schrodinger -20.98% -16.37% -8.19%

Does the media refer more to CERT or SDGR?

In the previous week, Schrodinger had 14 more articles in the media than Certara. MarketBeat recorded 15 mentions for Schrodinger and 1 mentions for Certara. Schrodinger's average media sentiment score of 0.71 beat Certara's score of -0.36 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Schrodinger 7 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Schrodinger (SDGR) Competitors

$29.23 -1.47 (-4.79%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$28.83 -0.40 (-1.37%)

As of 04:46 AM Eastern

Compare

SDGR vs. DOCS, WAY, HTFL, GDRX, and CERT

Should you buy Schrodinger stock or one of its competitors? Schrodinger's main competitors and comparable companies include Doximity (DOCS), Waystar (WAY), Heartflow (HTFL), GoodRx (GDRX), and Certara (CERT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Schrodinger compare to Doximity?

Schrodinger (NASDAQ:SDGR) and Doximity (NYSE:DOCS) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by insiders. Comparatively, 31.8% of Doximity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Schrodinger has a beta of 1.69, indicating that its stock price is 69% more volatile than the broader market. Comparatively, Doximity has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market.

In the previous week, Doximity had 20 more articles in the media than Schrodinger. MarketBeat recorded 35 mentions for Doximity and 15 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.71 beat Doximity's score of 0.01 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	7 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	2 Very Positive mention(s)	2 Positive mention(s)	26 Neutral mention(s)	2 Negative mention(s)	3 Very Negative mention(s)	Neutral

Schrodinger currently has a consensus target price of $20.50, indicating a potential downside of 29.87%. Doximity has a consensus target price of $32.18, indicating a potential upside of 21.33%. Given Doximity's higher possible upside, analysts plainly believe Doximity is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.24

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Doximity	25.48%	18.06%	15.40%

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$259.04M	8.33	-$103.26M	-$0.74	N/A
Doximity	$644.86M	7.33	$196.05M	$0.85	31.21

Summary

Doximity beats Schrodinger on 13 of the 17 factors compared between the two stocks.

How does Schrodinger compare to Waystar?

Schrodinger (NASDAQ:SDGR) and Waystar (NASDAQ:WAY) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Waystar	11.18%	7.03%	4.75%

79.1% of Schrodinger shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by insiders. Comparatively, 3.5% of Waystar shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$259.04M	8.33	-$103.26M	-$0.74	N/A
Waystar	$1.21B	3.94	$112.09M	$0.70	35.37

In the previous week, Schrodinger had 12 more articles in the media than Waystar. MarketBeat recorded 15 mentions for Schrodinger and 3 mentions for Waystar. Schrodinger's average media sentiment score of 0.71 beat Waystar's score of 0.50 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	7 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waystar	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Schrodinger currently has a consensus price target of $20.50, indicating a potential downside of 29.87%. Waystar has a consensus price target of $34.67, indicating a potential upside of 40.01%. Given Waystar's stronger consensus rating and higher possible upside, analysts clearly believe Waystar is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92

Schrodinger has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market. Comparatively, Waystar has a beta of 0.16, meaning that its share price is 84% less volatile than the broader market.

Summary

Waystar beats Schrodinger on 11 of the 17 factors compared between the two stocks.

How does Schrodinger compare to Heartflow?

Heartflow (NASDAQ:HTFL) and Schrodinger (NASDAQ:SDGR) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	23.41	-$116.79M	-$1.83	N/A
Schrodinger	$259.04M	8.33	-$103.26M	-$0.74	N/A

79.1% of Schrodinger shares are held by institutional investors. 7.7% of Heartflow shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Schrodinger	-20.98%	-16.37%	-8.19%

Heartflow currently has a consensus price target of $46.25, suggesting a potential downside of 2.41%. Schrodinger has a consensus price target of $20.50, suggesting a potential downside of 29.87%. Given Heartflow's stronger consensus rating and higher probable upside, equities research analysts clearly believe Heartflow is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

In the previous week, Heartflow had 2 more articles in the media than Schrodinger. MarketBeat recorded 17 mentions for Heartflow and 15 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.71 beat Heartflow's score of 0.35 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	6 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Schrodinger	7 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Schrodinger beats Heartflow on 9 of the 16 factors compared between the two stocks.

How does Schrodinger compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, Schrodinger had 15 more articles in the media than GoodRx. MarketBeat recorded 15 mentions for Schrodinger and 0 mentions for GoodRx. Schrodinger's average media sentiment score of 0.71 beat GoodRx's score of 0.00 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Overall Sentiment
GoodRx	Neutral
Schrodinger	Positive

GoodRx has a beta of 1.59, suggesting that its stock price is 59% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, suggesting that its stock price is 69% more volatile than the broader market.

GoodRx has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.43	$30.44M	$0.04	83.00
Schrodinger	$259.04M	8.33	-$103.26M	-$0.74	N/A

GoodRx has a net margin of 2.07% compared to Schrodinger's net margin of -20.98%. GoodRx's return on equity of 7.22% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Schrodinger	-20.98%	-16.37%	-8.19%

GoodRx currently has a consensus target price of $4.23, suggesting a potential upside of 27.33%. Schrodinger has a consensus target price of $20.50, suggesting a potential downside of 29.87%. Given GoodRx's higher probable upside, research analysts clearly believe GoodRx is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 5.9% of GoodRx shares are owned by company insiders. Comparatively, 10.1% of Schrodinger shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

GoodRx beats Schrodinger on 9 of the 16 factors compared between the two stocks.

How does Schrodinger compare to Certara?

Certara (NASDAQ:CERT) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Schrodinger	-20.98%	-16.37%	-8.19%

Certara presently has a consensus target price of $8.28, indicating a potential downside of 4.19%. Schrodinger has a consensus target price of $20.50, indicating a potential downside of 29.87%. Given Certara's stronger consensus rating and higher probable upside, research analysts clearly believe Certara is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$421.75M	3.12	-$1.60M	-$0.45	N/A
Schrodinger	$259.04M	8.33	-$103.26M	-$0.74	N/A

In the previous week, Schrodinger had 14 more articles in the media than Certara. MarketBeat recorded 15 mentions for Schrodinger and 1 mentions for Certara. Schrodinger's average media sentiment score of 0.71 beat Certara's score of -0.36 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Schrodinger	7 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Certara has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market.

74.0% of Certara shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 1.1% of Certara shares are held by insiders. Comparatively, 10.1% of Schrodinger shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Certara beats Schrodinger on 11 of the 17 factors compared between the two stocks.

Get Schrodinger News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SDGR vs. The Competition

Export

Metric	Schrodinger	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.27B	$1.72B	$7.31B	$13.29B
Dividend Yield	N/A	3.89%	2.52%	12.57%
P/E Ratio	-39.50	20.86	274.09	25.69
Price / Sales	8.33	88.98	642.55	79.71
Price / Cash	N/A	31.72	77.80	52.76
Price / Book	5.92	6.19	10.47	6.32
Net Income	-$103.26M	-$18.66M	$3.49B	$359.73M
7 Day Performance	-3.34%	-0.44%	-0.68%	0.17%
1 Month Performance	55.73%	1.76%	-3.18%	-3.27%
1 Year Performance	53.36%	-17.39%	15.12%	5.58%

Schrodinger Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SDGR Schrodinger	1.3322 of 5 stars	$29.23 -4.8%	$20.50 -29.9%	+53.4%	$2.27B	$259.04M	N/A	850	Insider Trade Gap Down
DOCS Doximity	4.3639 of 5 stars	$26.38 +3.1%	$32.18 +22.0%	N/A	$4.56B	$644.86M	31.03	880	Trending News
WAY Waystar	4.2676 of 5 stars	$24.90 +6.1%	$35.14 +41.1%	-34.4%	$4.50B	$1.10B	35.57	1,700	Positive News
HTFL Heartflow	1.8819 of 5 stars	$49.54 -0.7%	$44.88 -9.4%	+32.1%	$4.34B	$176.03M	N/A	843	Analyst Forecast Insider Trade
GDRX GoodRx	4.1552 of 5 stars	$3.56 +5.0%	$4.23 +18.7%	-17.8%	$1.16B	$796.85M	89.02	697	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SDGR) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Schrodinger (SDGR) Competitors

SDGR vs. DOCS, WAY, HTFL, GDRX, and CERT

How does Schrodinger compare to Doximity?

Summary

How does Schrodinger compare to Waystar?

Summary

How does Schrodinger compare to Heartflow?

Summary

How does Schrodinger compare to GoodRx?

Summary

How does Schrodinger compare to Certara?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SDGR vs. The Competition

Schrodinger Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Schrodinger (SDGR) Competitors

SDGR vs. DOCS, WAY, HTFL, GDRX, and CERT

How does Schrodinger compare to Doximity?

Do institutionals & insiders believe in SDGR or DOCS?

Which has more risk & volatility, SDGR or DOCS?

Does the media refer more to SDGR or DOCS?

Do analysts rate SDGR or DOCS?

Is SDGR or DOCS more profitable?

Which has higher earnings and valuation, SDGR or DOCS?

Summary

How does Schrodinger compare to Waystar?

Is SDGR or WAY more profitable?

Do institutionals and insiders believe in SDGR or WAY?

Which has better valuation and earnings, SDGR or WAY?

Does the media favor SDGR or WAY?

Do analysts rate SDGR or WAY?

Which has more risk and volatility, SDGR or WAY?

Summary

How does Schrodinger compare to Heartflow?

Which has better valuation and earnings, HTFL or SDGR?

Do institutionals & insiders hold more shares of HTFL or SDGR?

Is HTFL or SDGR more profitable?

Do analysts recommend HTFL or SDGR?

Does the media refer more to HTFL or SDGR?

Summary

How does Schrodinger compare to GoodRx?

Does the media prefer GDRX or SDGR?

Which has more risk and volatility, GDRX or SDGR?

Which has preferable valuation and earnings, GDRX or SDGR?

Is GDRX or SDGR more profitable?

Do analysts recommend GDRX or SDGR?

Do institutionals and insiders have more ownership in GDRX or SDGR?

Summary

How does Schrodinger compare to Certara?

Is CERT or SDGR more profitable?

Do analysts rate CERT or SDGR?

Which has preferable earnings and valuation, CERT or SDGR?

Does the media refer more to CERT or SDGR?

Which has more volatility & risk, CERT or SDGR?

Do institutionals & insiders believe in CERT or SDGR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SDGR vs. The Competition

Schrodinger Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools